/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Sex disparities in outcomes of left atrial appendage occlusion
Event: ESC Congress 2023
Topic: Left Atrial Appendage Closure
Session: Invasive management of atrial fibrillation: ablation and LAA closure
The role of infliximab in treating refractory cardiac sarcoidosis
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Heart failure red flags and their management
Impact of left ventricular ejection fraction on outcomes of cardiac resynchronisation therapy in cardiac sarcoidosis
Event: Heart Failure 2023
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Device therapy 1
The effect of delay in the diagnosis of cardiac sarcoidosis on heart failure outcomes in patients presenting with advanced AV block
Event: Heart Failure 2023
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Arrhythmias & device
Impact of cardiac resynchronisation therapy in patients with cardiac sarcoidosis
Event: ESC Congress 2022
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Heart failure: let’s re-synchronise please
ESC 365 is supported by
